ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 13 (1) 79 -93     DOI: 10.1677/erc.1.00988
Copyright © 2006 by the Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galli, G
Right arrow Articles by Brandi, M L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galli, G
Right arrow Articles by Brandi, M L

Characterization of the functional and growth properties of long-term cell cultures established from a human somatostatinoma

G Galli1, R Zonefrati1, A Gozzini1, C Mavilia1,4, V Martineti1,4, I Tognarini1, G Nesi2, T Marcucci3, F Tonelli3, M Tommasi3, C Casini Raggi3, P Pinzani3 and M L Brandi1,4

1 Department of Internal Medicine, University of Florence Medical School, Viale Pieraccini 6, 50139 Florence, Italy
2 Department of Pathology, University of Florence Medical School, Florence, Italy
3 Department of Clinical Physiopathology, University of Florence Medical School, Florence, Italy
4 DEGENE Spin-off, University of Florence Medical School, Florence, Italy

(Requests for offprints should be addressed to M L Brandi at Department of Internal Medicine, University of Florence; Email: m.brandi{at}dmi.unifi.it)

In somatostatinoma, a rare malignant somatostatin (SST)-secreting neoplasia, tumour regression is rarely observed, implying the need for novel antiproliferative strategies. Here, we characterized a long-term culture (SST-secreting cancer (SS-C cells)) established from a human somatostatinoma. High concentrations of SST and chromogranin A were released by SS-C cells and SST release was stimulated by depolarizing stimuli and inhibited by the SST analogue, octreotide. SS-C cells expressed mRNA for SST receptor (SSTR) subtypes 1, 2 and 4, being also able to bind native SST. Moreover, SS-C cells were positively stained with an antibody to SSTR2. SS-C cells also expressed interferon-{gamma} (IFN-{gamma}) receptor mRNA and measurable telomerase activity. Our findings indicate that in vitro exposure of SS-C cells to native SST-28, to octreotide, to IFN-{gamma}, or to 3'-azido-3'deoxythymidine (AZT), a telomerase inhibitor, results in inhibition of SS-C cell proliferation. Concomitant with growth inhibition, apoptosis was detected in SST-, octreotide-, IFN-{gamma}- or AZT-treated SS-C cell cultures. Taken together our results characterized native SST, SST analogues, IFN-{gamma} and a telomerase inhibitor as growth-inhibiting and proapoptotic stimuli in cultured human somatostatinoma cells. Based on these findings, the potential of SST analogues, IFN-{gamma} and AZT, alone or in combination, should be further explored in the medical treatment of somatostatinoma.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.